Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Response to a Letter to the Editor: Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.
J Physiol. 2024 May;602(9):2143-2144. doi: 10.1113/JP286650. Epub 2024 Apr 22.
J Physiol. 2024.
PMID: 38648379
No abstract available.
Proteomic Analysis of KCNK3 Loss of Expression Identified Dysregulated Pathways in Pulmonary Vascular Cells.
Le Ribeuz H, Dumont F, Ruellou G, Lambert M, Balliau T, Quatredeniers M, Girerd B, Cohen-Kaminsky S, Mercier O, Yen-Nicolaÿ S, Humbert M, Montani D, Capuano V, Antigny F.
Le Ribeuz H, et al.
Int J Mol Sci. 2020 Oct 7;21(19):7400. doi: 10.3390/ijms21197400.
Int J Mol Sci. 2020.
PMID: 33036472
Free PMC article.
Item in Clipboard
In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression.
Le Ribeuz H, Courboulin A, Ghigna MR, Lambert M, Hautefort A, Humbert M, Montani D, Cohen-Kaminsky S, Perros F, Antigny F.
Le Ribeuz H, et al.
Respir Res. 2020 Jul 16;21(1):186. doi: 10.1186/s12931-020-01444-7.
Respir Res. 2020.
PMID: 32678044
Free PMC article.
Item in Clipboard
Cite
Cite